258
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

ABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus

, MPH CPH (Medical Student) & , MD FACP FAASLD (Director) (Clinical Professor of Medicine) (Director) (Clinical Professor of Medicine)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vicente Soriano, Pablo Labarga, José V. Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M. Peña & Pablo Barreiro. (2017) Drug interactions in HIV-infected patients treated for hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 13:8, pages 807-816.
Read now
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M Peña & Vicente Soriano. (2015) Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects. Expert Opinion on Drug Safety 14:9, pages 1421-1434.
Read now

Articles from other publishers (5)

Rui Ren, Xin Wang, Zehui Xu & Wanglin Jiang. (2023) Paritaprevir ameliorates experimental acute lung injury in vitro and in vivo. Archives of Pharmacal Research 46:6, pages 564-572.
Crossref
A. Ferreira-Gonzalez. 2017. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology 485 501 .
N.A. Meanwell. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 553 627 .
Sabrina Waibel, Rosi Bissinger, Ghada Bouguerra, Salem Abbès & Florian Lang. (2016) Ritonavir-Induced Suicidal Death of Human Erythrocytes. Basic & Clinical Pharmacology & Toxicology 119:1, pages 51-57.
Crossref
Nghia H. Nguyen & Mindie H. Nguyen. (2015) Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterology Clinics of North America 44:4, pages 871-881.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.